KIRIN HLDGS CO LTD S/ADR (KNBWY)
KNBWY moved a median of 0.00% 30 minutes after news, and -0.18% by the close. How KNBWY actually reacts to news — the realized, point-in-time move the market made, measured across 61 labeled events over the last three years with zero look-ahead.
KNBWY’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 10% | 60 |
| 30-min | 0.00% | 34% | 61 |
| 60-min | -0.03% | 36% | 61 |
| to close | -0.18% | 34% | 61 |
| Middle 50% of KNBWY reactions | -0.23% to +0.08% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 61 |
Half of all KIRIN HLDGS CO LTD S/ADR news events land between -0.23% and +0.08% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when KNBWY moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to KNBWY's baseline. Nothing else.
Recent KNBWY events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo®) in Patients With Mycosis Fungoides and Sézary Syndrome | Press release | Business Wire | -0.99% | +0.40% | |
| Kirin and Blackmores Team Up to Release Cognitive Function Support Supplements in Australia and New Zealand Formulated with Kirin Group’s Cognizin® Citicoline | Press release | Business Wire | +0.00% | +0.91% | |
| European Commission Approves Crysvita® (burosumab) for Infants with X-linked Hypophosphataemia in the European Union | Press release | Business Wire | -0.06% | -0.17% | |
| The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH | Press release | GlobeNewswire | +0.00% | +0.35% | |
| Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL | Press release | GlobeNewswire | -7.46% | -2.29% | |
| FOUR ROSES DEBUTS ANTHOLOGY SERIES WITH OLDEST RELEASE IN BRAND HISTORY | Press release | PR Web | -0.08% | -0.49% | |
| FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH | Press release | GlobeNewswire | -3.21% | -1.97% | |
| CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program | Press release | GlobeNewswire | +0.00% | -0.58% | |
| Cowellnex and Metagen Launch Joint Research Utilizing Independently Acquired High-Precision Gut Microbiota Data | Press release | Business Wire | +0.00% | -0.09% | |
| KIRIN HYOKETSU Expands into U.S. RTD Market with Local Production | Press release | Business Wire | +0.00% | -1.23% | |
| Kirin and Immunosens Launch Joint Development of a Self-Testing Service That Uses Urinary IgA to Visualize a Person’s Immune Status | Press release | Business Wire | +0.00% | -0.32% | |
| Kyowa Kirin Announces Proposed Appointment of Abdul Mullick to President and Chief Executive Officer, While Former CEO Masashi Miyamoto to Remain Chairman | Press release | Business Wire | +0.00% | +0.00% | |
| Kirin: Development of a Fermented Ingredient Derived from Coffee Cherries to Enhance Body and Aroma Contributing to the Sustainability of Coffee Farms, Reduction of Environmental Impact, and Addressing Alcohol-related Social Issues | Press release | Business Wire | +0.00% | -1.19% | |
| Kyowa Kirin International Announces Appointment of Julie Dehaene-Puype as President for the Region | Press release | Business Wire | -0.41% | -0.74% | |
| Kyowa Kirin and Orchard Therapeutics Announce OTL-200 Granted Orphan Regenerative Medicine Product Designation for Early-onset MLD in Japan | Press release | GlobeNewswire | +0.00% | -1.57% | |
| Global Registry Data Show Meaningful Overall Survival Benefit in Patients with Advanced Cutaneous T-cell Lymphoma (CTCL) treated with POTELIGEO (mogamulizumab) | Press release | Business Wire | +0.00% | -3.28% | |
| KIRIN Develops Technology to Enhance Heat and Drought Tolerance in Hop Seedlings Contributing to a Sustainable Supply of Beer Ingredients Amid Climate Change | Press release | Business Wire | +0.00% | +0.17% | |
| Cognizin® Unveils a Mind-Body Connection Experience at Strong New York Showcasing Cognitive Health as the Next Frontier in Fitness | Press release | PR Web | +0.00% | +0.17% | |
| Supply Chain Consultancy TMX Transform Announces 304% U.S. CAGR Since Launching in 2022 | Press release | PR Web | +0.00% | -0.23% | |
| Kyowa Hakko Presents New Findings on Cognizin® Citicoline at ILSI Europe's 5th Symposium on Nutrition for the Ageing Brain | Press release | PR Web | +0.07% | +0.50% | |
| Experts Reveal Why Oral Glutathione Could Be The Smarter Choice Over IV Therapy | Press release | PR Web | +0.00% | +3.14% | |
| Announcing the Launch of 3pm AFTERNOON BITES™ First Snack in the U.S. Created to Help Overcome the 3PM Slump | Press release | PR Web | +0.00% | -0.18% | |
| Electrolyte Boost® Wins "Game On: Powered by Cognizin®" Tournament, Celebrating Brain Health and Sports Performance | Press release | PR Web | +0.00% | -1.04% | |
| Kyowa Hakko USA Celebrates Brain Awareness Week and highlights Cognizin® Citicoline's Cognitive benefits for Long-Term Brain Performance | Press release | PR Web | +0.00% | +0.25% | |
| Kirin Holdings: Conducting Human Rights Due Diligence For Sustainable Sourcing Of Sri Lankan Tea Leaves | Press release | Business Wire | +0.00% | -0.79% | |
| Kirin Holdings: Improving The Sustainability Of Black Tea Farms In Sri Lanka Through The Regenerative Tea Scorecard In Conjunction With The Rainforest Alliance | Press release | Business Wire | +0.00% | -0.79% | |
| Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe | Press release | Business Wire | +0.02% | -0.09% | |
| New Year, New Healthy Habits: What you initiate at the start of the year will benefit you inside and out every day | Press release | PR Web | +0.55% | -0.55% | |
| Kirin’s Electric Salt Spoon Shines At CES Innovation Awards 2025, Earning First-Ever Wins In Digital Health and Accessibility & Age Tech! | Press release | Business Wire | -0.08% | +0.00% | |
| Ai Energy Drink Launches Groundbreaking Formula with Cognizin® Citicoline to Support Brain Health and Cognitive Function | Press release | PR Web | -0.04% | -2.55% | |
| AMABIE™ Launches Sparkling Tonic Inspired by Japanese Legend and Powered by Postbiotic IMMUSE® | Press release | PR Web | +0.00% | +0.07% | |
| Natural Health Products Launches Best Daily Ever™ Glutathione Pixie Sticks: A Game-Changing Immune Support Solution for Kids | Press release | PR Web | — | -0.94% | |
| Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company | Press release | Business Wire | -0.02% | +0.20% | |
| Kyowa Hakko USA Receives U.S. Patent for Cognizin® Citicoline, Cementing Its Position as the Gold Standard Ingredient for Cognitive Health | Press release | PR Web | +0.00% | -2.91% | |
| Kyowa Kirin Announces Positive Interim Real-world Data for Mogamulizumab (Poteligeo®) in Cutaneous T-cell Lymphoma at EORTC-CLTG 2024 | Press release | Business Wire | +0.00% | -5.89% | |
| Kyowa Hakko USA's Cognizin® Validated in New Research, Featured in Exclusive SupplySide West Energy Drink Collaboration | Press release | PR Web | +0.03% | +0.20% | |
| Kyowa Kirin Presents Real-World Evidence Demonstrating Clinically Meaningful Impact of Burosumab Treatment in Adults with X-linked Hypophosphatemia | Press release | Business Wire | +2.67% | +4.32% | |
| Sober October: Do'Mo's Zero-Proof Elixirs with Cognizin® Revolutionize Alcohol-Free Socializing | Press release | PR Web | +0.00% | +0.72% | |
| New Analysis Demonstrates Impaired Work Productivity and Increased Unemployment Rates in Adults with X-linked Hypophosphataemia (XLH) | Press release | Business Wire | +0.00% | +0.69% | |
| Kyowa Kirin International and NewBridge Pharmaceuticals Enter Into Agreement to Improve Access to Medicines for Rare Disease Patients Across Middle East and North Africa | Press release | Business Wire | +0.00% | -1.42% | |
| DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific | Press release | PR Newswire | +0.00% | +2.00% | |
| Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary | Press release | Business Wire | +0.00% | -1.25% | |
| Kirin Holdings will begin online sales of "Electric Salt Spoon", a spoon that uses electricity to enhance salty and umami taste*1, on May 20 | Press release | Business Wire | +0.00% | -0.21% | |
| LC-Plasma-based Vaccine Research Selected for SCARDA Project | Press release | Business Wire | +0.00% | +3.00% | |
| Introducing Bobelo's Postbiotic Immunity with IMMUSE™ for the Whole Family | Press release | PR Web | +0.75% | +0.34% | |
| OLLY Launches New Cognitive Health Supplements With 'Focus Buddies Brainy L'OLLY Pops' Including Cognizin® Citicoline | Press release | PR Web | +0.00% | +0.41% | |
| ENCORE Introduces Innovative Beverage Mixes Featuring Science-Backed Cognizin® and IMMUSE™ for Cognitive and Beauty Support | Press release | PR Web | +0.00% | +0.00% | |
| First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome | Press release | Business Wire | +0.00% | +0.35% | |
| Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On Therapies | Press release | PR Newswire | +0.00% | -1.96% | |
| Karen E. Todd, VP Global Marketing of Kyowa Hakki U.S.A. Named MM+M 2024 WOMEN OF DISTINCTION Honoree | Press release | PR Web | +0.00% | +2.69% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the KNBWY section they belong to.
Where else KNBWY is measured.
KNBWY earnings → · Analyst actions → · SEC filings →
Other Consumer Defensive names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Planet Green Holdings Corp. (PLAG) | 63 | -0.17% | 44% |
| SLC AGRICOLA SA S/ADR (SLCJY) | 63 | 0.00% | 32% |
| Kp Tissue Inc (KPT_TSE) | 60 | 0.00% | 48% |
| Harrison, Vickers & Waterman, Inc. (HVCW) | 58 | +3.57% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Consumer Defensive names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is KIRIN HLDGS CO LTD S/ADR's median reaction calculated?
Every labeled KNBWY news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 61 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 34% of KNBWY's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does KNBWY's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.